Clinical and economic outcomes of patients with brain metastases based on symptoms: An argument for routine brain screening of those treated with upfront radiosurgery

Insurers have started to deny reimbursement for routine brain surveillance with magnetic resonance imaging (MRI) after stereotactic radiosurgery (SRS) for brain metastases in favor of symptom‐prompted imaging. The authors investigated the clinical and economic impact of symptomatic versus asymptomatic metastases and related these findings to the use of routine brain surveillance.

[1]  G. Horstmann,et al.  Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: Stereotactic radiosurgery versus surgical resection , 2013, Clinical Neurology and Neurosurgery.

[2]  E. Shaw,et al.  Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[3]  E. Shaw,et al.  Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. , 2011, Journal of neurosurgery.

[4]  James H. Nguyen,et al.  Timing and risk factors for new brain metastasis formation in patients initially treated only with Gamma Knife surgery. Clinical article. , 2011, Journal of neurosurgery.

[5]  J. Golfinos,et al.  Neurological complications and symptom resolution following Gamma Knife surgery for brain metastases 2 cm or smaller in relation to eloquent cortices. , 2010, Journal of neurosurgery.

[6]  M. Murawska,et al.  The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death. , 2010, International journal of radiation oncology, biology, physics.

[7]  A. Maas,et al.  RECOMBINANT FACTOR VIIA IN TRAUMATIC INTRACEREBRAL HEMORRHAGE: RESULTS OF A DOSE‐ESCALATION CLINICAL TRIAL , 2008, Neurosurgery.

[8]  Hiroki Shirato,et al.  Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial , 2007 .

[9]  L. Constine,et al.  The Role of Surveillance Magnetic Resonance Imaging (MRI) Scanning in Detecting Recurrent Brain Tumors in Asymptomatic Children , 2001, Journal of Neuro-Oncology.

[10]  N. Olgun,et al.  Surveillance imaging and cost effectivity in pediatric brain tumors. , 2003, European journal of radiology.

[11]  C. Ostertag,et al.  Radiosurgery followed by planned observation in patients with one to three brain metastases. , 2003, Neurosurgery.

[12]  L Souhami,et al.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. , 2000, International journal of radiation oncology, biology, physics.

[13]  W Curran,et al.  Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. , 2000, International journal of radiation oncology, biology, physics.

[14]  W R Markesbery,et al.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. , 1998, JAMA.

[15]  M. Mehta,et al.  A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. , 1997, International journal of radiation oncology, biology, physics.

[16]  J. Birkmeyer,et al.  Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. , 1995, Chest.

[17]  L D Lunsford,et al.  The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. , 1995, Neurosurgery.